30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Ocera Therapeutics Inc (OCRX)

Track

Stock chart
Ticker: OCRX Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Byrnes Michael
CFO and Treasurer
1 purchase — total 3,854 USD
Buy 28 Mar 2017
Value US$1,787,461.40 | Price 26.70 | Shares 59,315
Buy 7 Dec 2016
Value US$4,506,086.65 | Price 494.19 | Shares 2,484
Buy 13 Oct 2016
Value US$6,597.50 | Price 2.64 | Shares 2,500
Sale 12 Sep 2016
Value US$169.61 | Price 2.29 | Shares 74
Sale 12 Sep 2016
Value US$2,443.27 | Price 2.29 | Shares 1,066
Sale 12 Sep 2016
Value US$12,312.62 | Price 2.29 | Shares 5,372
Buy 4 Mar 2016
Value US$9,570.00 | Price 3.19 | Shares 3,000
Buy 22 Jan 2016
Value US$23,800.00 | Price 2.38 | Shares 10,000
Buy 15 Jan 2016
Value US$20,800.00 | Price 2.08 | Shares 10,000
Buy 15 Jan 2016
Value US$21,500.00 | Price 2.15 | Shares 10,000
Buy 15 Jan 2016
Value US$7,245.00 | Price 2.07 | Shares 3,500
Buy 23 Jun 2015
Value US$18,550.00 | Price 3.71 | Shares 5,000
Buy 7 May 2015
Value US$20,048.50 | Price 3.97 | Shares 5,050
Buy 6 May 2015
Value US$27,150.00 | Price 3.62 | Shares 7,500
Buy 6 May 2015
Value US$9,025.00 | Price 3.61 | Shares 2,500
Buy 6 May 2015
Value US$111,900.00 | Price 3.73 | Shares 30,000
Buy 1 Oct 2014
Value US$9,620.00 | Price 4.81 | Shares 2,000
Buy 11 Jul 2014
Value US$17,487.00 | Price 5.83 | Shares 3,000
Buy 11 Jul 2014
Value US$59,280.00 | Price 5.93 | Shares 10,000
Buy 15 Jul 2013
Value US$2,599,999.88 | Price 6.03 | Shares 431,435
Buy 15 Jul 2013
Value US$26,516.16 | Price 6.03 | Shares 4,400
Buy 15 Jul 2013
Value US$385,430.46 | Price 6.03 | Shares 63,957
Buy 15 Jul 2013
Value US$1,945,376.16 | Price 6.03 | Shares 322,809
Buy 15 Jul 2013
Value US$26,516.16 | Price 6.03 | Shares 4,400
Buy 15 Jul 2013
Value US$385,430.46 | Price 6.03 | Shares 63,957
Buy 15 Jul 2013
Value US$1,945,376.16 | Price 6.03 | Shares 322,809
Buy 15 Jul 2013
Value US$1,999,999.45 | Price 6.03 | Shares 331,873
Buy 15 Jul 2013
Value US$44,191.59 | Price 6.03 | Shares 7,333
Buy 15 Jul 2013
Value US$5,955,800.72 | Price 6.03 | Shares 988,285
Buy 15 Jul 2013
Value US$1,999,999.45 | Price 6.03 | Shares 331,873
Buy 15 Jul 2013
Value US$44,191.59 | Price 6.03 | Shares 7,333
Buy 15 Jul 2013
Value US$5,955,800.72 | Price 6.03 | Shares 988,285
Buy 15 Jul 2013
Value US$1,999,999.45 | Price 6.03 | Shares 331,873
Buy 15 Jul 2013
Value US$44,191.59 | Price 6.03 | Shares 7,333
Buy 15 Jul 2013
Value US$5,955,800.72 | Price 6.03 | Shares 988,285
Buy 15 Jul 2013
Value US$1,999,999.45 | Price 6.03 | Shares 331,873
Buy 15 Jul 2013
Value US$44,191.59 | Price 6.03 | Shares 7,333
Buy 15 Jul 2013
Value US$5,955,800.72 | Price 6.03 | Shares 988,285
Buy 15 Jul 2013
Value US$1,999,999.45 | Price 6.03 | Shares 331,873
Buy 15 Jul 2013
Value US$44,191.59 | Price 6.03 | Shares 7,333
Buy 15 Jul 2013
Value US$5,955,800.72 | Price 6.03 | Shares 988,285
Buy 15 Jul 2013
Value US$1,999,999.45 | Price 6.03 | Shares 331,873
Buy 15 Jul 2013
Value US$44,191.59 | Price 6.03 | Shares 7,333
Buy 15 Jul 2013
Value US$5,955,800.72 | Price 6.03 | Shares 988,285
Buy 15 Jul 2013
Value US$1,999,999.45 | Price 6.03 | Shares 331,873
Buy 14 Mar 2012
Value US$13,801.26 | Price 3.01 | Shares 4,592
Buy 14 Mar 2012
Value US$22,370.42 | Price 2.99 | Shares 7,484
Buy 14 Mar 2012
Value US$103,821.99 | Price 3.01 | Shares 34,544
Buy 14 Mar 2012
Value US$168,268.40 | Price 2.99 | Shares 56,294
Buy 14 Mar 2012
Value US$2,735.00 | Price 3.01 | Shares 910
Buy 14 Mar 2012
Value US$4,429.85 | Price 2.99 | Shares 1,482
Buy 13 Mar 2012
Value US$46,143.40 | Price 2.96 | Shares 15,599
Buy 13 Mar 2012
Value US$470,382.27 | Price 2.96 | Shares 159,015
Buy 13 Mar 2012
Value US$12,382.61 | Price 2.96 | Shares 4,186
Buy 12 Mar 2012
Value US$143,276.85 | Price 2.55 | Shares 56,187
Buy 12 Mar 2012
Value US$75,229.84 | Price 2.34 | Shares 32,155
Buy 12 Mar 2012
Value US$8,158.81 | Price 1.87 | Shares 4,363
Buy 12 Mar 2012
Value US$3,019.17 | Price 1.89 | Shares 1,601
Buy 12 Mar 2012
Value US$1,460,479.35 | Price 2.55 | Shares 572,737
Buy 12 Mar 2012
Value US$766,848.35 | Price 2.34 | Shares 327,769
Buy 12 Mar 2012
Value US$83,153.29 | Price 1.87 | Shares 44,467
Buy 12 Mar 2012
Value US$30,787.57 | Price 1.89 | Shares 16,326
Buy 12 Mar 2012
Value US$38,443.80 | Price 2.55 | Shares 15,076
Buy 12 Mar 2012
Value US$20,186.07 | Price 2.34 | Shares 8,628
Buy 12 Mar 2012
Value US$2,187.90 | Price 1.87 | Shares 1,170
Buy 12 Mar 2012
Value US$810.89 | Price 1.89 | Shares 430
Buy 30 Sep 2011
Value US$2,709.00 | Price 2.58 | Shares 1,050
Buy 6 Apr 2011
Value US$4,000,000.00 | Price 4.00 | Shares 1,000,000
Buy 6 Apr 2011
Value US$11,864.00 | Price 4.00 | Shares 2,966
Buy 6 Apr 2011
Value US$58,272.00 | Price 4.00 | Shares 14,568
Buy 6 Apr 2011
Value US$3,179,864.00 | Price 4.00 | Shares 794,966
Buy 6 Apr 2011
Value US$3,250,000.00 | Price 4.00 | Shares 812,500
Buy 6 Apr 2011
Value US$1,500,000.00 | Price 4.00 | Shares 375,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2017-03-28 2017-03-28 B Purchase Byrnes Michael

CFO and Treasurer
59,315 +18.0%
26.70
US$1,787,461 		59,315 +18.0% 26.70 US$1,787,461
2016-12-08 2016-12-07 B Purchase Grais Linda S

President and CEO

Executive Director
2,484 -29.2%
494.19
US$4,506,087 		2,484 -29.2% 494.19 US$4,506,087
2016-10-17 2016-10-13 B Purchase Bukofzer Stan

Chief Medical Officer

Officer
74,805 +17.7%
205.40
US$4,744,979 		74,805 +17.7% 205.40 US$4,744,979
2016-12-30 2016-09-12 S Sale POWELL MICHAEL Non-Executive Director
74 -0.8%
2.29
US$170 		74 -0.8% 2.29 US$170
2016-12-30 2016-09-12 S Sale POWELL MICHAEL Non-Executive Director
1,066 -0.8%
2.29
US$2,443 		1,066 -0.8% 2.29 US$2,443
2016-12-30 2016-09-12 S Sale POWELL MICHAEL Non-Executive Director
5,372 -0.8%
2.29
US$12,313 		5,372 -0.8% 2.29 US$12,313
2016-03-07 2016-03-04 B Purchase Grais Linda S

President and CEO

Executive Director
3,000 +5.0%
3.19
US$9,570 		3,000 +5.0% 3.19 US$9,570
2016-01-25 2016-01-22 B Purchase Grais Linda S

President and CEO

Executive Director
10,000 +20.0%
2.38
US$23,800 		10,000 +20.0% 2.38 US$23,800
2016-01-19 2016-01-15 B Purchase Grais Linda S

President and CEO

Executive Director
10,000 +25.0%
2.08
US$20,800 		10,000 +25.0% 2.08 US$20,800
2016-01-19 2016-01-15 B Purchase Aggarwal Gaurav

Chief Business Officer

Officer
10,000 +100.0%
2.15
US$21,500 		10,000 +100.0% 2.15 US$21,500
2016-01-19 2016-01-15 B Purchase Byrnes Michael

CFO and Treasurer

Officer
3,500 +53.8%
2.07
US$7,245 		3,500 +53.8% 2.07 US$7,245
2015-06-24 2015-06-23 B Purchase WIERENGA WENDALL Non-Executive Director
5,000 +inf%
3.71
US$18,550 		5,000 +inf% 3.71 US$18,550
2015-05-07 2015-05-07 B Purchase Patni Rajiv

Chief Development Officer

Officer
5,050 +inf%
3.97
US$20,048 		5,050 +inf% 3.97 US$20,048
2015-05-06 2015-05-06 B Purchase Aggarwal Gaurav

Chief Business Officer

Officer
7,500 +300.0%
3.62
US$27,150 		7,500 +300.0% 3.62 US$27,150
2015-05-06 2015-05-06 B Purchase Byrnes Michael

CFO and Treasurer

Officer
2,500 +62.5%
3.61
US$9,025 		2,500 +62.5% 3.61 US$9,025
2015-05-06 2015-05-06 B Purchase Grais Linda S

President and CEO

Executive Director
30,000 +300.0%
3.73
US$111,900 		30,000 +300.0% 3.73 US$111,900
2014-10-02 2014-10-01 B Purchase Byrnes Michael

VP, Finance & Treasurer

Officer
2,000 +100.0%
4.81
US$9,620 		2,000 +100.0% 4.81 US$9,620
2014-07-15 2014-07-11 B Purchase TETLOW SHARON

Acting CFO & Treasurer

Officer
3,000 +inf%
5.83
US$17,487 		3,000 +inf% 5.83 US$17,487
2014-07-15 2014-07-11 B Purchase Grais Linda S

President and CEO

Executive Director
10,000 +inf%
5.93
US$59,280 		10,000 +inf% 5.93 US$59,280
2013-07-17 2013-07-15 B Purchase Kjellson Nina S Non-Executive Director
431,435 +109.4%
6.03
US$2,600,000 		431,435 +109.4% 6.03 US$2,600,000
2013-07-17 2013-07-15 B Purchase SOFINNOVA VENTURE PARTNERS VI L P Large shareholder
4,400 +45.9%
6.03
US$26,516 		4,400 +45.9% 6.03 US$26,516
2013-07-17 2013-07-15 B Purchase SOFINNOVA VENTURE PARTNERS VI L P Large shareholder
63,957 +45.9%
6.03
US$385,430 		63,957 +45.9% 6.03 US$385,430
2013-07-17 2013-07-15 B Purchase POWELL MICHAEL Non-Executive Director
4,400 +45.9%
6.03
US$26,516 		4,400 +45.9% 6.03 US$26,516
2013-07-17 2013-07-15 B Purchase POWELL MICHAEL Non-Executive Director
63,957 +45.9%
6.03
US$385,430 		63,957 +45.9% 6.03 US$385,430
2013-07-17 2013-07-15 B Purchase POWELL MICHAEL Non-Executive Director
322,809 +45.9%
6.03
US$1,945,376 		322,809 +45.9% 6.03 US$1,945,376
2013-07-17 2013-07-15 B Purchase SOFINNOVA VENTURE PARTNERS VI L P Large shareholder
322,809 +45.9%
6.03
US$1,945,376 		322,809 +45.9% 6.03 US$1,945,376
2013-07-16 2013-07-15 B Purchase BLAIR JAMES C Large shareholder
331,873 +21.2%
6.03
US$1,999,999 		331,873 +21.2% 6.03 US$1,999,999
2013-07-16 2013-07-15 B Purchase BLAIR JAMES C Large shareholder
7,333 +inf%
6.03
US$44,192 		7,333 +inf% 6.03 US$44,192
2013-07-16 2013-07-15 B Purchase SCHOEMAKER KATHLEEN K Large shareholder
331,873 +21.2%
6.03
US$1,999,999 		331,873 +21.2% 6.03 US$1,999,999
2013-07-16 2013-07-15 B Purchase SCHOEMAKER KATHLEEN K Large shareholder
7,333 +inf%
6.03
US$44,192 		7,333 +inf% 6.03 US$44,192
2013-07-16 2013-07-15 B Purchase Halak Brian K Large shareholder
331,873 +21.2%
6.03
US$1,999,999 		331,873 +21.2% 6.03 US$1,999,999
2013-07-16 2013-07-15 B Purchase Halak Brian K Large shareholder
7,333 +inf%
6.03
US$44,192 		7,333 +inf% 6.03 US$44,192
2013-07-16 2013-07-15 B Purchase TREU JESSE I Large shareholder
331,873 +21.2%
6.03
US$1,999,999 		331,873 +21.2% 6.03 US$1,999,999
2013-07-16 2013-07-15 B Purchase TREU JESSE I Large shareholder
7,333 +inf%
6.03
US$44,192 		7,333 +inf% 6.03 US$44,192
2013-07-16 2013-07-15 B Purchase VITULLO NICOLE Large shareholder
331,873 +21.2%
6.03
US$1,999,999 		331,873 +21.2% 6.03 US$1,999,999
2013-07-16 2013-07-15 B Purchase VITULLO NICOLE Large shareholder
7,333 +inf%
6.03
US$44,192 		7,333 +inf% 6.03 US$44,192
2013-07-16 2013-07-15 B Purchase DOVEY BRIAN H Large shareholder
331,873 +21.2%
6.03
US$1,999,999 		331,873 +21.2% 6.03 US$1,999,999
2013-07-16 2013-07-15 B Purchase DOVEY BRIAN H Large shareholder
7,333 +inf%
6.03
US$44,192 		7,333 +inf% 6.03 US$44,192
2013-07-16 2013-07-15 B Purchase Domain Partners VI, L.P. Large shareholder
331,873 +21.2%
6.03
US$1,999,999 		331,873 +21.2% 6.03 US$1,999,999
2013-07-16 2013-07-15 B Purchase BLAIR JAMES C Large shareholder
988,285 +inf%
6.03
US$5,955,801 		988,285 +inf% 6.03 US$5,955,801
2013-07-16 2013-07-15 B Purchase SCHOEMAKER KATHLEEN K Large shareholder
988,285 +inf%
6.03
US$5,955,801 		988,285 +inf% 6.03 US$5,955,801
2013-07-16 2013-07-15 B Purchase Halak Brian K Large shareholder
988,285 +inf%
6.03
US$5,955,801 		988,285 +inf% 6.03 US$5,955,801
2013-07-16 2013-07-15 B Purchase TREU JESSE I Large shareholder
988,285 +inf%
6.03
US$5,955,801 		988,285 +inf% 6.03 US$5,955,801
2013-07-16 2013-07-15 B Purchase VITULLO NICOLE Large shareholder
988,285 +inf%
6.03
US$5,955,801 		988,285 +inf% 6.03 US$5,955,801
2013-07-16 2013-07-15 B Purchase DOVEY BRIAN H Large shareholder
988,285 +inf%
6.03
US$5,955,801 		988,285 +inf% 6.03 US$5,955,801
2012-03-14 2012-03-14 B Purchase Baker Biotech Capital (GP), LLC Large shareholder
4,592 +2.0%
3.01
US$13,801 		4,592 +2.0% 3.01 US$13,801
2012-03-14 2012-03-14 B Purchase Baker Biotech Capital (GP), LLC Large shareholder
7,484 +3.4%
2.99
US$22,370 		7,484 +3.4% 2.99 US$22,370
2012-03-14 2012-03-14 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
34,544 +1.0%
3.01
US$103,822 		34,544 +1.0% 3.01 US$103,822
2012-03-14 2012-03-14 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
56,294 +1.6%
2.99
US$168,268 		56,294 +1.6% 2.99 US$168,268
2012-03-14 2012-03-14 B Purchase 14159 capital (GP), LLC Large shareholder
910 +1.6%
3.01
US$2,735 		910 +1.6% 3.01 US$2,735
2012-03-14 2012-03-14 B Purchase 14159 capital (GP), LLC Large shareholder
1,482 +2.7%
2.99
US$4,430 		1,482 +2.7% 2.99 US$4,430
2012-03-14 2012-03-13 B Purchase Baker Biotech Capital (GP), LLC Large shareholder
15,599 +7.6%
2.96
US$46,143 		15,599 +7.6% 2.96 US$46,143
2012-03-14 2012-03-13 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
159,015 +4.8%
2.96
US$470,382 		159,015 +4.8% 2.96 US$470,382
2012-03-14 2012-03-13 B Purchase 14159 capital (GP), LLC Large shareholder
4,186 +8.2%
2.96
US$12,383 		4,186 +8.2% 2.96 US$12,383
2012-03-14 2012-03-12 B Purchase Baker Biotech Capital (GP), LLC Large shareholder
56,187 +37.9%
2.55
US$143,277 		56,187 +37.9% 2.55 US$143,277
2012-03-14 2012-03-12 B Purchase Baker Biotech Capital (GP), LLC Large shareholder
32,155 +27.7%
2.34
US$75,230 		32,155 +27.7% 2.34 US$75,230
2012-03-14 2012-03-12 B Purchase Baker Biotech Capital (GP), LLC Large shareholder
4,363 +3.9%
1.87
US$8,159 		4,363 +3.9% 1.87 US$8,159
2012-03-14 2012-03-12 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
572,737 +21.1%
2.55
US$1,460,479 		572,737 +21.1% 2.55 US$1,460,479
2012-03-14 2012-03-12 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
327,769 +13.7%
2.34
US$766,848 		327,769 +13.7% 2.34 US$766,848
2012-03-14 2012-03-12 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
44,467 +1.9%
1.87
US$83,153 		44,467 +1.9% 1.87 US$83,153
2012-03-14 2012-03-12 B Purchase 14159 capital (GP), LLC Large shareholder
15,076 +41.8%
2.55
US$38,444 		15,076 +41.8% 2.55 US$38,444
2012-03-14 2012-03-12 B Purchase 14159 capital (GP), LLC Large shareholder
8,628 +31.5%
2.34
US$20,186 		8,628 +31.5% 2.34 US$20,186
2012-03-14 2012-03-12 B Purchase 14159 capital (GP), LLC Large shareholder
1,170 +4.5%
1.87
US$2,188 		1,170 +4.5% 1.87 US$2,188
2012-03-14 2012-03-12 B Purchase Baker Biotech Capital (GP), LLC Large shareholder
1,601 +1.5%
1.89
US$3,019 		1,601 +1.5% 1.89 US$3,019
2012-03-14 2012-03-12 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
16,326 +0.7%
1.89
US$30,788 		16,326 +0.7% 1.89 US$30,788
2012-03-14 2012-03-12 B Purchase 14159 capital (GP), LLC Large shareholder
430 +1.7%
1.89
US$811 		430 +1.7% 1.89 US$811
2011-10-04 2011-09-30 B Purchase Moore David

VP, Commercial Operations

Officer
1,050 +inf%
2.58
US$2,709 		1,050 +inf% 2.58 US$2,709
2011-04-06 2011-04-06 B Purchase BDC CAPITAL INC. Large shareholder
1,000,000 +80.7%
4.00
US$4,000,000 		1,000,000 +80.7% 4.00 US$4,000,000
2011-04-06 2011-04-06 B Purchase THOMAS MCNERNEY & PARTNERS LP Large shareholder
2,966 +0.1%
4.00
US$11,864 		2,966 +0.1% 4.00 US$11,864
2011-04-06 2011-04-06 B Purchase THOMAS MCNERNEY & PARTNERS LP Large shareholder
14,568 +0.5%
4.00
US$58,272 		14,568 +0.5% 4.00 US$58,272
2011-04-06 2011-04-06 B Purchase THOMAS MCNERNEY & PARTNERS LP Large shareholder
794,966 +36.3%
4.00
US$3,179,864 		794,966 +36.3% 4.00 US$3,179,864
2011-04-06 2011-04-06 B Purchase H.I.G. Ventures - Tranzyme, LLC Large shareholder
812,500 +37.1%
4.00
US$3,250,000 		812,500 +37.1% 4.00 US$3,250,000
2011-04-06 2011-04-06 B Purchase QUAKER BIO VENTURES LP Large shareholder
375,000 +17.1%
4.00
US$1,500,000 		375,000 +17.1% 4.00 US$1,500,000
Explore more

More insider trading research around Ocera Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America